Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamics.

The structure of a recently reported neurotrophic ligand, 3-(3-pyridyl)-1-propyl(2S)-1-(3,3-dimethyl-1, 2-dioxopentyl)-2-pyrrolidinecarboxylate, in complex with FKBP12 was determined using heteronuclear NMR spectroscopy. The inhibitor exhibits a binding mode analogous to that observed for the macrocycle FK506, used widely as an immunosuppressant, with the prolyl ring replacing the pipecolyl moiety and the amide bond in a trans conformation. However, fewer favourable protein-ligand interactions are detected in the structure of the complex, suggesting weaker binding compared with the immunosuppressant drug. Indeed, a micromolar dissociation constant was estimated from the NMR ligand titration profile, in contrast to the previously published nanomolar inhibition activity. Although the inhibitor possesses a remarkable structural simplicity with respect to FK506, 15N relaxation studies show that it induces similar effects on the protein dynamics, stabilizing the conformation of solvent-exposed residues which are important for mediating the interaction of immunophilin/ligand complexes with molecular targets and potentially for the transmission of the neurotrophic action of FKBP12 inhibitors.

[1]  Academician D. V. Skobel’tsyn Analysis of Experimental Results , 1969 .

[2]  G. Bodenhausen,et al.  Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy , 1980 .

[3]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Analysis of experimental results , 1982 .

[4]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .

[5]  K. Wüthrich,et al.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.

[6]  A. J. Shaka,et al.  Computer-optimized decoupling scheme for wideband applications and low-level operation , 1985 .

[7]  S. Fesik,et al.  Heteronuclear three-dimensional nmr spectroscopy. A strategy for the simplification of homonuclear two-dimensional NMR spectra , 1988 .

[8]  A. Gronenborn,et al.  Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2. , 1988, Protein engineering.

[9]  A. Gronenborn,et al.  Determination of three‐dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms Circumventing problems associated with folding , 1988, FEBS letters.

[10]  L. Kay,et al.  Overcoming the overlap problem in the assignment of 1H NMR spectra of larger proteins by use of three-dimensional heteronuclear 1H-15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: application to interleukin 1 beta. , 1989, Biochemistry.

[11]  Ad Bax,et al.  Rapid recording of 2D NMR spectra without phase cycling. Application to the study of hydrogen exchange in proteins , 1989 .

[12]  R F Standaert,et al.  Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex , 1991, Science.

[13]  M. Karplus,et al.  Proton and nitrogen sequential assignments and secondary structure determination of the human FK506 and rapamycin binding protein. , 1991, Biochemistry.

[14]  P. Wright,et al.  Intramolecular motions of a zinc finger DNA-binding domain from Xfin characterized by proton-detected natural abundance carbon-13 heteronuclear NMR spectroscopy , 1991 .

[15]  A. Burny,et al.  An immunophilin that binds M(r) 90,000 heat shock protein: main structural features of a mammalian p59 protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Petros,et al.  Conformation of two non‐immunosuppressive FK506 analogs when bound to FKBP by isotope‐filtered NMR , 1992, FEBS letters.

[17]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[18]  J. Keeler,et al.  Experiments for recording pure-absorption heteronuclear correlation spectra using pulsed field gradients , 1992 .

[19]  Paul A. Keifer,et al.  Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity , 1992 .

[20]  M Ikura,et al.  Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. , 1992, Biochemistry.

[21]  V. Saudek,et al.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.

[22]  S. Grzesiek,et al.  Correlation of Backbone Amide and Aliphatic Side-Chain Resonances in 13C/15N-Enriched Proteins by Isotropic Mixing of 13C Magnetization , 1993 .

[23]  K. Constantine,et al.  Characterization of the backbone dynamics of an anti‐digoxin antibody VL domain by inverse detected 1H–15N NMR: Comparisons with X‐ray data for the Fab , 1993, Proteins.

[24]  A. Petros,et al.  Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. , 1993, Biochemistry.

[25]  J. Fulghum,et al.  Nitrogen-15 NMR relaxation studies of the FK506 binding protein: Backbone dynamics of the uncomplexed receptor , 1993 .

[26]  Vladimir Sklenar,et al.  Gradient-Tailored Water Suppression for 1H-15N HSQC Experiments Optimized to Retain Full Sensitivity , 1993 .

[27]  S. Grzesiek,et al.  The Importance of Not Saturating H2o in Protein NMR : application to Sensitivity Enhancement and Noe Measurements , 1993 .

[28]  L. Kay,et al.  A Gradient-Enhanced HCCH-TOCSY Experiment for Recording Side-Chain 1H and 13C Correlations in H2O Samples of Proteins , 1993 .

[29]  A. J. Shaka,et al.  A Simple Windowless Mixing Sequence to Suppress Cross Relaxation in TOCSY Experiments , 1993 .

[30]  J. Moore,et al.  15N NMR relaxation studies of the FK506 binding protein: dynamic effects of ligand binding and implications for calcineurin recognition. , 1994, Biochemistry.

[31]  Jon Clardy,et al.  DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12. , 1994 .

[32]  E. B. George,et al.  Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Caron,et al.  X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex , 1995, Cell.

[34]  M. Murcko,et al.  Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506. , 1995, Acta crystallographica. Section D, Biological crystallography.

[35]  M. Murcko,et al.  Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin. , 1995, Acta crystallographica. Section D, Biological crystallography.

[36]  M Nilges,et al.  Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. , 1995, Journal of molecular biology.

[37]  L. Kay,et al.  Spectral density function mapping using 15N relaxation data exclusively , 1995, Journal of biomolecular NMR.

[38]  M Geyer,et al.  AURELIA, a program for computer-aided analysis of multidimensional NMR spectra , 1995, Journal of biomolecular NMR.

[39]  K. Nagayama,et al.  Protein backbone dynamics revealed by quasi spectral density function analysis of amide N-15 nuclei. , 1995, Biochemistry.

[40]  Anna Tempczyk,et al.  Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex , 1995, Nature.

[41]  J. Lefèvre,et al.  Internal mobility in the partially folded DNA binding and dimerization domains of GAL4: NMR analysis of the N-H spectral density functions. , 1996, Biochemistry.

[42]  D. Knighton,et al.  Structure-based design of novel, urea-containing FKBP12 inhibitors. , 1996, Journal of medicinal chemistry.

[43]  K. Ogura,et al.  An improved double-tuned and isotope-filtered pulse scheme based on a pulsed field gradient and a wide-band inversion shaped pulse , 1996, Journal of biomolecular NMR.

[44]  E. Baulieu,et al.  Three-dimensional structure of the immunophilin-like domain of FKBP59 in solution. , 1996, Biochemistry.

[45]  J. Lefèvre,et al.  Theory and practice of nuclear spin relaxation in proteins. , 1996, Annual review of physical chemistry.

[46]  T. Logan,et al.  Simple, distortion-free homonuclear spectra of peptides and nucleic acids in water using excitation sculpting. , 1996, Journal of magnetic resonance. Series B.

[47]  R. Hrabal,et al.  Gradient-enhanced TOCSY experiments with improved sensitivity and solvent suppression , 1996, Journal of biomolecular NMR.

[48]  P. Hajduk,et al.  Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.

[49]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[50]  J. H. Li,et al.  Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Hajduk,et al.  Discovering High-Affinity Ligands for Proteins , 1997, Science.

[52]  G J Kleywegt,et al.  Model building and refinement practice. , 1997, Methods in enzymology.

[53]  D. S. Garrett,et al.  Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of the Escherichia coli phosphotransferase system. , 1997, Biochemistry.

[54]  P. Chaturvedi,et al.  A Nonimmunosuppressant FKBP-12 Ligand Increases Nerve Regeneration , 1997, Experimental Neurology.

[55]  Neuroimmunophilin Ligands as Novel Therapeutics for the Treatment of Degenerative Disorders of the Nervous System , 1997 .

[56]  Michael Nilges,et al.  Floating stereospecific assignment revisited: Application to an 18 kDa protein and comparison with J-coupling data , 1997, Journal of biomolecular NMR.

[57]  P. Suzdak,et al.  FKBP12-binding domain analogues of FK506 are potent, nonimmunosuppressive neurotrophic agents in vitro and promote recovery in a mouse model of Parkinson's disease , 1997 .

[58]  S. Snyder,et al.  Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A , 1997, Nature Medicine.

[59]  R. Babine,et al.  MOLECULAR RECOGNITION OF PROTEIN-LIGAND COMPLEXES : APPLICATIONS TO DRUG DESIGN , 1997 .

[60]  W. Jahnke,et al.  Chemical shift as a probe of molecular interfaces: NMR studies of DNA binding by the three amino-terminal zinc finger domains from transcription factor IIIA , 1998, Journal of biomolecular NMR.

[61]  N. Letvin,et al.  Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination , 1998, Nature Medicine.

[62]  S. Snyder,et al.  Neural actions of immunophilin ligands. , 1998, Trends in pharmacological sciences.

[63]  M L Lamb,et al.  Investigations of neurotrophic inhibitors of FK506 binding protein via Monte Carlo simulations. , 1998, Journal of medicinal chemistry.

[64]  B. Stockman NMR spectroscopy as a tool for structure-based drug design , 1998 .

[65]  J Rotonda,et al.  32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein. , 1999, Journal of medicinal chemistry.

[66]  R. Glockshuber,et al.  Pilus chaperone FimC–adhesin FimH interactions mapped by TROSY-NMR , 1999, Nature Structural Biology.

[67]  Georg C. Terstappen,et al.  High Throughput Scintillation Proximity Assay for the Identification of FKBP-12 Ligands , 1999, Journal of biomolecular screening.

[68]  P Burkhard,et al.  The discovery of steroids and other novel FKBP inhibitors using a molecular docking program. , 1999, Journal of molecular biology.

[69]  M. Matzuk,et al.  Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. , 1999, The Journal of pharmacology and experimental therapeutics.

[70]  G C Roberts,et al.  NMR spectroscopy in structure-based drug design. , 1999, Current opinion in biotechnology.